World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
75
Citations
24484
World Ranking
1965
National Ranking
962

Overview

Thomas M. Folks is affiliated with the Centers for Disease Control and Prevention in the United States. Their research primarily spans the field of Medicine, with focused subfields in Pathology and Forensic Medicine as well as Infectious Diseases.

The scientist's work covers several specialized topics, including:

  • Autoimmune Bullous Skin Diseases
  • Parvovirus B19 Infection Studies
  • Systemic Sclerosis and Related Diseases

Thomas M. Folks has contributed to scholarly literature with publications appearing in the venue UNC Libraries. A notable recent paper includes:

  • HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges, 2021, UNC Libraries

Their collaborative work involves frequent coauthors such as Dennis Ellenberger, Ronald A. Otten, Bin Li, Michael Aidoo, and Irma Rodriguez. Each of these collaborators appears in multiple joint contributions.

Best Publications

  • Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

    Akio Adachi;Howard E. Gendelman;Scott Koenig;Thomas Folks

  • Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

    Thomas M. Folks;Jesse Justement;Audrey Kinter;Charles A. Dinarello

  • Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.

    Elia J. Duh;Wendy J. Maury;Thomas M. Folks;Anthony S. Fauci

  • Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.

    Thomas M. Folks;Kathleen A. Clouse;Jesse Justement;Arnold Rabson

  • Activation of HIV gene expression during monocyte differentiation by induction of NF-kB

    George E. Griffin;Kwanyee Leung;Thomas M. Folks;Steven Kunkel

  • The HIV 'A' (sor) gene product is essential for virus infectivity.

    Klaus Strebel;Daryl Daugherty;Kathleen Clouse;David Cohen

  • A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection.

    Dedra Buchwald;Paul R. Cheney;Daniel L. Peterson;Berch Henry

  • Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters

    Nathan D. Wolfe;Walid Heneine;Jean K. Carr;Albert D. Garcia

  • Naturally acquired simian retrovirus infections in central African hunters

    Nathan D Wolfe;William M Switzer;Jean K Carr;Vinod B Bhullar

  • No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts

    Walid Heneine;Annika Tibell;William M Switzer;Paul Sandstrom

  • Human neutrophils increase expression of C3bi as well as C3b receptors upon activation.

    M. Berger;J. O'Shea;A. S. Cross;T. M. Folks

  • Biological and biochemical characterization of a cloned leu-3− cell surviving infection with the acquired immune deficiency syndrome retrovirus

    T. M. Folks;D. Powell;M. Lightfoote;S. Koenig

  • Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir.

    J. Gerardo García-Lerma;Ron A. Otten;Shoukat H. Qari;Eddie Jackson

  • Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus

    T. Folks;S. Benn;A. Rabson;T. Theodore

  • Contribution of Immune Activation to the Pathogenesis and Transmission of Human Immunodeficiency Virus Type 1 Infection

    Stephen D. Lawn;Salvatore T. Butera;Thomas M. Folks

  • Interferon-α but not AZT suppresses HIV expression in chronically infected cell lines

    Guido Poli;Jan M. Orenstein;Audrey Kinter;Thomas M. Folks

  • Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: Implications for treatment and postexposure prophylaxis

    Myriam Witvrouw;Christophe Pannecouque;William M Switzer;Thomas M Folks

  • Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2).

    Ron A. Otten;Dawn K. Smith;Debra R. Adams;Jennifer K. Pullium

  • Identification of a Human Population Infected With Simian Foamy Viruses

    Walid Heneine;William M. Switzer;Paul Sandstrom;Jennifer Brown

  • Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus.

    Ronald L. Willey;Rosamond A. Rutledge;Susan Dias;Thomas Folks

  • Chemoprophylaxis with Tenofovir Disoproxil Fumarate Provided Partial Protection against Infection with Simian Human Immunodeficiency Virus in Macaques Given Multiple Virus Challenges

    Shambavi Subbarao;Ronald A. Otten;Artur Ramos;Caryn Kim

  • Risk of nosocomial infection with human T-cell lymphotropic virus type III/lymphadenopathy-associated virus in a large cohort of intensively exposed health care workers.

    Henderson Dk;Saah Aj;Zak Bj;Kaslow Ra

Frequent Co-Authors

Walid Heneine
Walid Heneine Centers for Disease Control and Prevention
William M. Switzer
William M. Switzer Centers for Disease Control and Prevention
Renu B. Lal
Renu B. Lal Centers for Disease Control and Prevention
Donald S. Burke
Donald S. Burke University of Pittsburgh
Marcia L. Kalish
Marcia L. Kalish Centers for Disease Control and Prevention
Nathan D. Wolfe
Nathan D. Wolfe Global Viral
Francois Villinger
Francois Villinger University of Louisiana at Lafayette
Michael Dale Lairmore
Michael Dale Lairmore University of California, Davis
Gary J. Nabel
Gary J. Nabel ModeX Therapeutics
Aftab A. Ansari
Aftab A. Ansari University of California, Davis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, exploring related healthcare degrees can open diverse career pathways. Many students consider nursing as a complementary field, especially since it plays a critical role in patient care and clinical research.

If you’re transitioning from a non-nursing background, several reputable online absn programs for non nurses offer accelerated options to jumpstart your nursing career. These programs equip you quickly with the practical skills needed for the healthcare setting.

Additionally, accelerated nursing programs provide a streamlined path for students already holding a degree to earn their BSN without the extended timeline of traditional routes. This can be especially beneficial for immunology students seeking clinical experience.

For those interested in more entry-level nursing roles, the best easiest lpn programs to get into can provide accessible training with flexible options, allowing faster entry into the workforce while gaining foundational nursing knowledge.

To further advance your career, consider easiest online nurse practitioner programs. These offer opportunities to specialize and take on greater responsibilities, aligning well with an immunology background focused on patient care and treatment.

Exploring these related degrees can enhance your qualifications and expand your impact within health sciences and immunology-driven professions.

Best Scientists Citing Thomas M. Folks

Trending Scientists

Recently Published Articles